Discovery To Cure Revenue
Research Services • 
New Haven, Connecticut, United States • 1-10 Employees
$
Discovery To Cure revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Discovery To Cure
Denise Ben-Haim
Associate Director
Company overview
| Headquarters | 310 Cedar Street, New Haven, CT 06510, US |
| Website | |
| NAICS | 5417 |
| Keywords | Research, Cancer, Women, Brca, Ovarian Cancer, Endometrial Cancer, Uterine Cancer, Beverly Levy Walk, Discovery To Cure, Parp Inhibitors |
| Founded | 2003 |
| Employees | 1-10 |
| Socials |
About Discovery To Cure
Giving Families Hope, through provider education, early detection, personalized care, cutting edge research and community awareness for the curing and prevention of women's reproductive cancers.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
Discovery To Cure has never raised funding before.
Australia
Italy
GermanyFrequently asked questions
Discovery To Cure is located in New Haven, Connecticut, US.
Discovery To Cure generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
Discovery To Cure has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Discovery To Cure was founded in 2003, making it 23 years old. The company has established itself as a significant player in its industry over this time.
Discovery To Cure has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
